Age-Specific Global Prevalence of Hepatitis B, Hepatitis C, HIV, and Tuberculosis Among Incarcerated People: A Systematic Review

Overview

Journal J Adolesc Health

Publisher Elsevier

Specialty Pediatrics

Date 2018 Feb 20

PMID 29455713

Citations 13

Authors

Stuart A Kinner

Kathryn Snow

Andrea L Wirtz

Frederick L Altice

Chris Beyrer

Kate Dolan

Affiliations

Soon will be listed here.

Abstract

Purpose: This study aims to compare the global prevalence of hepatitis B, hepatitis C, HIV, and tuberculosis in incarcerated adolescents and young adults (AYAs) and older prisoners.

Methods: This study is a systematic review and meta-analysis of studies reporting the age-specific prevalence of each infection in prisoners. We grouped age-specific prevalence estimates into three overlapping age categories: AYA prisoners (<25 years), older prisoners (≥25 years), and mixed category (spanning age 25 years). We used random effects meta-analysis to estimate the relative risk (RR) of each infection in AYAs versus older prisoners.

Results: Among 72 studies, there was marked heterogeneity in prevalence estimates among AYA prisoners for all infections: hepatitis B (.4%-25.2%), hepatitis C (.0%-70.6%), HIV (.0%-15.8%), and active tuberculosis (.0%-3.7%). The pooled prevalence of HIV (RR = .39, 95% confidence interval .29-.53, I = 79.2%) and hepatitis C (RR = .51, 95% confidence interval .33-.78, I = 97.8%) was lower in AYAs than in older prisoners.

Conclusions: The prevalence of HIV and hepatitis C is lower in AYA prisoners than in older prisoners. Despite lower prevalence, acquisition begins early among incarcerated populations. There is an urgent need for targeted, age-appropriate prevention, treatment, and harm reduction measures in and beyond custodial settings to reduce the incidence of infection in these extremely vulnerable young people.

Citing Articles

SEROPREVALENCE OF HBsAg, HCV AND HIV AND ASSOCIATED RISK FACTORS IN A CORRECTIONAL FACILITY IN SOUTHERN NIGERIA: A CROSS-SECTIONAL STUDY.

Egbi O, Oyedepo D, Edeki I, Aladeh D, Ujah T, Okpiri J Ann Ib Postgrad Med. 2025; 22(2):54-60.

PMID: 40007706 PMC: 11848359.

European Committee for the Prevention of Torture and Inhuman or Degrading Treatment reporting on the provision of prison needle and syringe programmes in the Council of Europe region.

Van Hout M, Klankwarth U, Fleissner S, Stover H Public Health Pract (Oxf). 2024; 8:100544.

PMID: 39386980 PMC: 11462376. DOI: 10.1016/j.puhip.2024.100544.

Burden of tuberculosis among vulnerable populations worldwide: an overview of systematic reviews.

Litvinjenko S, Magwood O, Wu S, Wei X Lancet Infect Dis. 2023; 23(12):1395-1407.

PMID: 37696278 PMC: 10665202. DOI: 10.1016/S1473-3099(23)00372-9.

Seroprevalence and factors associated with hepatitis B virus exposure in the incarcerated population from southern Brazil.

de Gois J, Guedes S, Vieira A, Follador F, Dip L, Lucio L PLoS One. 2022; 17(11):e0278029.

PMID: 36413542 PMC: 9681091. DOI: 10.1371/journal.pone.0278029.

Prevalence of sexually transmitted infections and associated risk behaviors in prisoners: A systematic review.

SeyedAlinaghi S, Pashaei Z, Rahimi E, Saeidi S, Mirzapour P, Noori T Health Sci Rep. 2022; 5(5):e819.

PMID: 36177400 PMC: 9478043. DOI: 10.1002/hsr2.819.

References

Dolan K, Wodak A . HIV transmission in a prison system in an Australian State. Med J Aust. 1999; 171(1):14-7. DOI: 10.5694/j.1326-5377.1999.tb123490.x. View

Corbett E, Marston B, Churchyard G, De Cock K . Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet. 2006; 367(9514):926-37. DOI: 10.1016/S0140-6736(06)68383-9. View

Milloy M, Kerr T, Buxton J, Rhodes T, Guillemi S, Hogg R . Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis. 2011; 203(9):1215-21. PMC: 3069731. DOI: 10.1093/infdis/jir032. View

van Dooren K, Kinner S, Hellard M . A comparison of risk factors for hepatitis C among young and older adult prisoners. J Correct Health Care. 2014; 20(4):280-91. DOI: 10.1177/1078345814541536. View

Springer S, Qiu J, Saber-Tehrani A, Altice F . Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners. PLoS One. 2012; 7(5):e38335. PMC: 3365007. DOI: 10.1371/journal.pone.0038335. View

Larney S, Mahowald M, Scharff N, Flanigan T, Beckwith C, Zaller N . Epidemiology of hepatitis C virus in Pennsylvania state prisons, 2004-2012: limitations of 1945-1965 birth cohort screening in correctional settings. Am J Public Health. 2014; 104(6):e69-74. PMC: 4062024. DOI: 10.2105/AJPH.2014.301943. View

Nogueira P, Abrahao R, Galesi V . Tuberculosis and latent tuberculosis in prison inmates. Rev Saude Publica. 2012; 46(1):119-27. DOI: 10.1590/s0034-89102011005000080. View

Comstock G, Woolpert S . Preventive treatment of untreated, nonactive tuberculosis in an Eskimo population. Arch Environ Health. 1972; 25(5):333-7. DOI: 10.1080/00039896.1972.10666182. View

Harawa N, Bingham T, Butler Q, Dalton K, Cunningham W, Behel S . Using arrest charge to screen for undiagnosed HIV infection among new arrestees: a study in Los Angeles County. J Correct Health Care. 2009; 15(2):105-17. PMC: 3175428. DOI: 10.1177/1078345808330038. View

10.

Miller E, Bi P, Ryan P . Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors. Int J Infect Dis. 2008; 13(2):201-8. DOI: 10.1016/j.ijid.2008.06.011. View

11.

Teplin L, Elkington K, McClelland G, Abram K, Mericle A, Washburn J . Major mental disorders, substance use disorders, comorbidity, and HIV-AIDS risk behaviors in juvenile detainees. Psychiatr Serv. 2005; 56(7):823-8. PMC: 1557408. DOI: 10.1176/appi.ps.56.7.823. View

12.

Burek V, Horvat J, Butorac K, Mikulic R . Viral hepatitis B, C and HIV infection in Croatian prisons. Epidemiol Infect. 2010; 138(11):1610-20. DOI: 10.1017/S0950268810000476. View

13.

Milloy M, Buxton J, Wood E, Li K, Montaner J, Kerr T . Elevated HIV risk behaviour among recently incarcerated injection drug users in a Canadian setting: a longitudinal analysis. BMC Public Health. 2009; 9:156. PMC: 2695456. DOI: 10.1186/1471-2458-9-156. View

14.

Cunningham E, Hajarizadeh B, Bretana N, Amin J, Betz-Stablein B, Dore G . Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study. J Viral Hepat. 2017; 24(9):733-741. DOI: 10.1111/jvh.12701. View

15.

Campollo O, Roman S, Panduro A, Hernandez G, Diaz-Barriga L, Balanzario M . Non-injection drug use and hepatitis C among drug treatment clients in west central Mexico. Drug Alcohol Depend. 2011; 123(1-3):269-72. DOI: 10.1016/j.drugalcdep.2011.11.009. View

16.

Nelson P, Mathers B, Cowie B, Hagan H, Des Jarlais D, Horyniak D . Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011; 378(9791):571-83. PMC: 3285467. DOI: 10.1016/S0140-6736(11)61097-0. View

17.

Risser W, Smith K . Tuberculosis in incarcerated youth in Texas. JAMA. 2005; 293(22):2716-7. DOI: 10.1001/jama.293.22.2716. View

18.

Murray C, Ortblad K, Guinovart C, Lim S, Wolock T, Roberts D . Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384(9947):1005-70. PMC: 4202387. DOI: 10.1016/S0140-6736(14)60844-8. View

19.

Jones A, Cremin I, Abdullah F, Idoko J, Cherutich P, Kilonzo N . Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination prevention. Lancet. 2014; 384(9939):272-9. DOI: 10.1016/S0140-6736(13)62230-8. View

20.

Fialho M, Messias M, Page-Shafer K, Farre L, Schmalb M, Pedral-Sampaio D . Prevalence and risk of blood-borne and sexually transmitted viral infections in incarcerated youth in Salvador, Brazil: opportunity and obligation for intervention. AIDS Behav. 2008; 12(4 Suppl):S17-24. DOI: 10.1007/s10461-008-9409-x. View